Breaking News Instant updates and real-time market news.

T

AT&T

$32.39

0.19 (0.59%)

, GOOG

Alphabet

$1,167.86

-5.77 (-0.49%)

18:17
06/19/18
06/19
18:17
06/19/18
18:17

AT&T in discussions to purchase AppNexus, Cheddar reports

AT&T (T) is in talks to acquire adtech company AppNexus, Cheddar reports. The deal would bolster the carrier's ad offerings in an effort to compete with the likes of Google (GOOG) and Facebook (FB), the report notes. Talks between the two parties are in advanced stages and a deal could be announced in the next few weeks, the report says, citing people familiar with the discussions. A source close to AppNexus told Cheddar that the company wouldn't sell for less than $2B. Reference Link

T

AT&T

$32.39

0.19 (0.59%)

GOOG

Alphabet

$1,167.86

-5.77 (-0.49%)

GOOGL

Alphabet Class A

$1,178.29

-5.69 (-0.48%)

FB

Facebook

$197.46

-0.84 (-0.42%)

  • 19

    Jun

  • 28

    Oct

T AT&T
$32.39

0.19 (0.59%)

06/19/18
06/19/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Mattel (MAT) downgraded to Neutral from Buy at UBS with analyst Arpine Kocharyan citing the stock's recent 35% appreciation with little change in fundamentals. 2. F5 Networks (FFIV) downgraded to Neutral from Buy at Citi with analyst Jim Suva saying with the stock up 38% year-to-date, the company's price-to-earnings valuation multiple has increased from 14.8 times at the start of the year to 17.8 times. 3. Dr Pepper Snapple (DPS) downgraded to Hold from Buy at Stifel with analyst Mark Swartzberg saying the more he learns about Keurig Green Mountain, the more he is convinced it has "limited capacity for operating income growth." 4. Red Hat (RHT) downgraded to Market Perform from Outperform at Raymond James with analyst Michael Turits saying shares are at peak valuation and the company is facing a difficult NTM growth outlook. 5. AT&T (T) downgraded to a Neutral after resuming coverage from Overweight at JPMorgan with analyst Philip Cusick saying he believes reversal of the Time Warner acquisition by the Department of Justice is "very unlikely" and would not be surprised to see AT&T shares "rebound fairly quickly after a period of deal-related flowback." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/19/18
JPMS
06/19/18
DOWNGRADE
Target $36
JPMS
Neutral
AT&T resumed with a Neutral from Overweight at JPMorgan
JPMorgan analyst Philip Cusick downgraded AT&T (T) to Neutral with a $36 price target following a period a restriction. His firm had an Overweight rating on AT&T before going restricted in October of 2016. The analyst believes reversal of the Time Warner acquisition by the Department of Justice is "very unlikely" and would not be surprised to see AT&T shares "rebound fairly quickly after a period of deal-related flowback." Cusick, however, prefers shares of Verizon (VZ) citing a "slightly higher multiple but less video-related margin pressure."
06/15/18
06/15/18
DOWNGRADE
Target $24

Sell
Juniper downgraded to Sell on key account weakening at Rosenblatt
As previously reported, Rosenblatt analyst Ryan Koontz downgraded Juniper (JNPR) to Sell from Neutral, stating that he believes the company is starting to see weakness in several key accounts, including AT&T (T), Comcast (CMCSA), and Alphabet (GOOGL). Those three customers collectively represent about 15% of sales, Koontz estimates. He cut his second half revenue and EPS estimates for Juniper to below consensus and lowered his price target on the shares to $24 from $28.
06/13/18
LOOP
06/13/18
DOWNGRADE
Target $100
LOOP
Hold
Time Warner downgraded to Hold from Buy at Loop Capital
Loop Capital analyst Alan Gould downgraded Time Warner (TWX) to Hold from Buy and lowered his price target to $100 from $107.50 after the affirmative federal judge ruling on AT&T (T) bid. Gould says he expects the merger to close by June 20th, and also recommends that investors shift their holdings to CBS (CBS), which may be the next attractive acquisition target in the industry.
GOOG Alphabet
$1,167.86

-5.77 (-0.49%)

06/18/18
SBSH
06/18/18
NO CHANGE
SBSH
Buy
Citi sees potential Q2 upside for Alphabet
Checks with two leading digital marketing agencies suggest growth in Google search spend remained strong in Q2, Citi analyst Mark May tells investors in a research note. The analyst believes there could be modest upside to consensus revenue forecasts and keeps a Buy rating on Alphabet shares.
06/18/18
CHLM
06/18/18
NO CHANGE
Target $120
CHLM
Buy
Weight Watchers price target raised to $120 from $100 at Craig-Hallum
Craig-Hallum analyst Alex Fuhrman raised his price target for Weight Watchers (WTW) to $120 from $100 as TV advertising campaign kicks off with new commercial launch. The analyst also believes Google (GOOG; GOOGL) searches are set to meaningfully accelerate and will likely move the stock higher before Q2 results are reported. Fuhrman reiterates a Buy rating on Weight Watchers shares.
06/19/18
WELS
06/19/18
NO CHANGE
Target $53
WELS
Outperform
JD.com price target raised to $53 from $47 at Wells Fargo
Wells Fargo analyst Ken Sena raised his price target for JD.com (JD) to $53 from $47 after the company and Google (GOOG; GOOGL) announced that the latter will invest $550M in cash in JD.com as part of a strategic partnership. The analyst believes this partnership adds to JD's strong list of existing data and strategic partnerships with Tencent (TCEHY), Walmart (WMT), Baidu (BIDU), Qihoo 360 and Vipshop (VIPS). Sena reiterates an Outperform rating on JD.com shares.
GOOGL Alphabet Class A
$1,178.29

-5.69 (-0.48%)

FB Facebook
$197.46

-0.84 (-0.42%)

06/13/18
MSCO
06/13/18
NO CHANGE
MSCO
Morgan Stanley says AT&T ruling may help narrow public/private media value gap
Morgan Stanley analyst Benjamin Swinburne said the court approval of AT&T's (T) acquisition of Time Warner (TWX) without conditions recognized the reality of new competition in the form of content investments from players such as Netflix (NFLX), Google's (GOOGL) YouTube, Amazon (AMZN), Apple (AAPL) and Facebook (FB). This ruling sends a "clear message to other industry players" and market uncertainty on deal prospects could fall, which could mean that equity values will likely rise accordingly, Swinburne tells investors. He notes there remains a large gap, which may now narrow, between private market valuations and public multiples in many parts of media and cable, pointing to Discovery Inc. (DISCK) as an example illustrating that point.
06/11/18
KEYB
06/11/18
NO CHANGE
Target $245
KEYB
Overweight
Instagram could be primary growth driver by 2020, says KeyBanc
KeyBanc analyst Andy Hargreaves believes Facebook's Instagram will drive 27% of incremental ad revenue in 2018, going up to 58% by 2020, at which point he estimates the service will have over 1.4B MAU and over $22B of revenue. Given the immense data set of Facebook's combined properties, the massive Instagram opportunity, and the potential of multiple other billion-user products, the analyst recommends buying Facebook. Hargreaves reiterates an Overweight rating and $245 price target on the shares.
06/11/18
JEFF
06/11/18
UPGRADE
Target $50
JEFF
Buy
Match Group upgraded to Buy from Hold at Jefferies
Jefferies analyst Brent Thill upgraded Match Group (MTCH) to Buy and raised his price target for the shares to $50 from $40. The stock closed Friday up 65c to $41.52. A survey of 600 online daters shows many users do not wish to commingle dating with social media, Thill tells investors in a research note. As such, he believes Facebook's (FB) dating will likely appeal to an older demographic rather than millennials on Tinder. The analyst notes that many past Facebook product launches have not impacted publicly traded competition.
06/06/18
DBAB
06/06/18
NO CHANGE
DBAB
Hold
Audience reach data show improving trends at Snap, says Deutsche Bank
Audience reach data show improving trends at Snap (SNAP) and stability at Facebook (FB) despite the General Data Protection Regulation rollout in Europe, Deutsche Bank analysts Lloyd Walmsley and Kunal Madhukar tells investors in a research note. The analysts "feel better" about Snap daily active user growth, and the shares, after looking at the latest trends in the Snapchat self-serve ad platform data. They reiterate a Buy rating on Facebook and Hold rating on Snap. On the latter, the analysts cite their below consensus estimates and the stock's "lack valuation support" for staying neutral on Snap.

TODAY'S FREE FLY STORIES

TTWO

Take-Two

$118.48

-2.03 (-1.68%)

, SNE

Sony

$54.73

-1.05 (-1.88%)

12:54
10/23/18
10/23
12:54
10/23/18
12:54
OnTheFly
Game On: Morgan Stanley sees big changes to gaming console market »

NEW RELEASES: The major…

TTWO

Take-Two

$118.48

-2.03 (-1.68%)

SNE

Sony

$54.73

-1.05 (-1.88%)

MSFT

Microsoft

$106.92

-2.72 (-2.48%)

UBSFY

Ubisoft

$0.00

(0.00%)

NTDOY

Nintendo

$0.00

(0.00%)

ATVI

Activision Blizzard

$68.32

-1.46 (-2.09%)

EA

Electronic Arts

$99.12

-2.25 (-2.22%)

GOOG

Alphabet

$1,090.88

-9.64 (-0.88%)

GOOGL

Alphabet Class A

$1,100.71

-10.49 (-0.94%)

AMZN

Amazon.com

$1,744.10

-44.9 (-2.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

SELB

Selecta Biosciences

$10.01

-3.36 (-25.13%)

12:54
10/23/18
10/23
12:54
10/23/18
12:54
Hot Stocks
Selecta Biosciences slides after new interim data from Phase 2 trial of SEL-212 »

Shares of Selecta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SCYX

Scynexis

$0.94

-0.0491 (-4.99%)

12:53
10/23/18
10/23
12:53
10/23/18
12:53
Recommendations
Scynexis analyst commentary  »

Scynexis shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

AKAM

Akamai

$64.21

-1.04 (-1.59%)

12:53
10/23/18
10/23
12:53
10/23/18
12:53
Hot Stocks
Verimatrix acquires the assets of AIS from Akamai »

Verimatrix, a specialist…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 01

    Nov

  • 13

    Nov

ASTE

Astec

$38.67

-8.65 (-18.28%)

12:50
10/23/18
10/23
12:50
10/23/18
12:50
Downgrade
Astec rating change  »

Astec downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

AAL

American Airlines

$31.72

-0.45 (-1.40%)

12:50
10/23/18
10/23
12:50
10/23/18
12:50
Options
10K American Airlines Nov 32 calls bought for $1.25, tied to 400K shares »

10K American Airlines Nov…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

SELB

Selecta Biosciences

$9.80

-3.57 (-26.70%)

12:47
10/23/18
10/23
12:47
10/23/18
12:47
Recommendations
Selecta Biosciences analyst commentary  »

Selecta Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SPY

SPDR S&P 500 ETF Trust

$271.39

-3.63 (-1.32%)

, SPX

S&P 500

$0.00

(0.00%)

12:47
10/23/18
10/23
12:47
10/23/18
12:47
Periodicals
Top White House advisor Kudlow says new tax cuts may be delayed, Hill says »

According to the Hill, On…

SPY

SPDR S&P 500 ETF Trust

$271.39

-3.63 (-1.32%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASTE

Astec

$38.42

-8.9 (-18.81%)

12:45
10/23/18
10/23
12:45
10/23/18
12:45
Downgrade
Astec rating change  »

Astec downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

12:45
10/23/18
10/23
12:45
10/23/18
12:45
General news
FX Action: USD-CAD »

FX Action: USD-CAD fell…

KHC

Kraft Heinz

$55.92

-0.3 (-0.53%)

12:41
10/23/18
10/23
12:41
10/23/18
12:41
Periodicals
Kraft Heinz to sell Indian asset portfolio to Zydus, Bloomberg reports »

Kraft Heinz has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 01

    Nov

V

Visa

$137.16

-3.48 (-2.47%)

12:40
10/23/18
10/23
12:40
10/23/18
12:40
Options
Visa calls lead puts 2:1 in heavy option volume as earnings approach »

Visa calls lead puts 2:1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 13

    Nov

  • 26

    Nov

  • 29

    Jan

LH

LabCorp

$166.46

-2.9 (-1.71%)

12:35
10/23/18
10/23
12:35
10/23/18
12:35
Recommendations
LabCorp analyst commentary  »

LabCorp recent selloff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

ABX

Barrick Gold

$13.36

0.27 (2.06%)

, GOLD

Randgold

$83.26

1.47 (1.80%)

12:35
10/23/18
10/23
12:35
10/23/18
12:35
Hot Stocks
Barrick Gold says Glass Lewis urges holders vote for merger resolutions »

Barrick Gold Corporation…

ABX

Barrick Gold

$13.36

0.27 (2.06%)

GOLD

Randgold

$83.26

1.47 (1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:35
10/23/18
10/23
12:35
10/23/18
12:35
General news
Treasury 2-year auction preview: the auction should go ok »

Treasury 2-year auction…

HZNP

Horizon Pharma

$18.06

-1.19 (-6.18%)

, SELB

Selecta Biosciences

$9.72

-3.65 (-27.30%)

12:33
10/23/18
10/23
12:33
10/23/18
12:33
Recommendations
Horizon Pharma, Selecta Biosciences analyst commentary  »

Cowen says Horizon…

HZNP

Horizon Pharma

$18.06

-1.19 (-6.18%)

SELB

Selecta Biosciences

$9.72

-3.65 (-27.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 07

    Nov

  • 27

    Nov

CIDM

Cinedigm

$0.94

(0.00%)

12:33
10/23/18
10/23
12:33
10/23/18
12:33
Hot Stocks
Cinedigm in partnership with Chinese streaming channel Youku »

Cinedigm announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

OC

Owens Corning

$48.25

-0.47 (-0.96%)

12:32
10/23/18
10/23
12:32
10/23/18
12:32
Downgrade
Owens Corning rating change  »

Owens Corning downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

FXI

iShares China Large-Cap ETF

$39.47

-1.06 (-2.62%)

12:30
10/23/18
10/23
12:30
10/23/18
12:30
Options
50K iShares Large Cap China Fund Dec 42 - 45 call spreads bought for 48c »

50K iShares Large Cap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$138.10

-0.58 (-0.42%)

, ITCI

Intra-Cellular

$16.83

-0.38 (-2.21%)

12:25
10/23/18
10/23
12:25
10/23/18
12:25
Conference/Events
JPMorgan pharma and biotech analysts to hold analyst/industry conference call »

Smid Cap Biotech Analyst…

JNJ

Johnson & Johnson

$138.10

-0.58 (-0.42%)

ITCI

Intra-Cellular

$16.83

-0.38 (-2.21%)

AGN

Allergan

$185.90

-1.85 (-0.99%)

SAGE

Sage Therapeutics

$118.28

0.25 (0.21%)

ALKS

Alkermes

$39.00

0.14 (0.36%)

ACAD

Acadia

$21.76

-0.01 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 28

    Oct

  • 30

    Oct

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 19

    Dec

  • 31

    Jan

EDU

New Oriental Education

$52.99

-9.76 (-15.55%)

12:22
10/23/18
10/23
12:22
10/23/18
12:22
Downgrade
New Oriental Education rating change  »

Follow-up: New Oriental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 01

    Nov

  • 02

    Nov

TSLA

Tesla

$279.50

18.47 (7.08%)

12:21
10/23/18
10/23
12:21
10/23/18
12:21
Periodicals
Mox Reports joins Citron in going long Tesla »

Mox Reports tweeted:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

IQV

Iqvia

$119.62

-6.74 (-5.33%)

12:20
10/23/18
10/23
12:20
10/23/18
12:20
Options
Vote of confidence in IQVIA Holdings after earnings »

Vote of confidence in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NXE

NexGen Energy

$1.89

-0.085 (-4.30%)

12:17
10/23/18
10/23
12:17
10/23/18
12:17
Conference/Events
NexGen Energy management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
10/23/18
10/23
12:17
10/23/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.